抄読会

腫瘍内科では、毎週月曜日に抄読会を行っています。様々な癌腫の最新の臨床試験から薬物動態に関するものまで、幅広い分野の論文を元に討論を行っています。

2015年度抄読会

出席者（敬称略）: 滝口、岩澤、植原、今井、江畑、栗本、志村、山本、南、研修医、学部学生

月 日   title
4 6 Lancet Oncol 2015; 16: 221–32 Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2) : a randomised, controlled, open-label phase 2 trial
13 Lancet Oncol 2015;Published online April 1 Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
20 J Gastroenterol 2014;5 October Streptozocin chemotherapy for advanced/metastatic well-differentiated neuroendocrine tumors: an analysis of a multi-center survey in Japan
27 Lancet Oncol 2011;12(11):1045-1052 Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes.
5 11 J Clin Oncol 2015;33:1460-1466. Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study
18 N Engl J Med 2015;372:1689-99. AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
25 Lancet Respir Med 2015;3: 282–89 Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial
6 1 J Clin Oncol 33:1438-1445. Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial
8 Lancet Oncol 2014; 15: 1224–35 Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
15 Lancet Oncol 2015; Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX Lung 6
22 J Clin Oncol 2015;33:1653-1659. Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial